A mouse model with postnatal endolymphatic hydrops and hearing loss
Introduction
Endolymphatic hydrops was first found to be associated with Meniere’s disease (MD) by Hallpike and Cairns, 1938, Yamakawa, 1938. The significance of ELH in the development of symptoms in patients with MD has been recognized by many investigators, and the histological finding of Reissner’s membrane distension is taken to be the hallmark of ELH (Arenberg et al., 1970, Belal and Ylikoski, 1980, Fraysse et al., 1980, Paparella, 1984, Schuknecht, 1976). However, ELH occurs in conditions other than Meniere’s disease, including delayed endolymphatic hydrops following trauma (Dodson et al., 2007), relapsing polychondritis (Murata et al., 2006), and some cases of acoustic neuroma (Mahmud et al., 2003). Unfortunately, current therapies directed at alleviating symptoms via presumed amelioration of ELH using diuretics and shunt surgery have been largely unsuccessful in preventing the progression of hearing deterioration in patients with ELH-related disorders. This is due, in part, to a lack of understanding of the relationship among ELH, hearing loss and neural degeneration. Animal models are necessary since appropriate human specimens are difficult to obtain.
Kimura and Schucknecht developed in 1965 a guinea pig model of ELH (Kimura and Schuknecht, 1965). ELH is achieved in this model by surgical obliteration of the endolymphatic duct (ED), and distention of Reissner’s membrane ensues days to weeks after surgery. The guinea pig model has proven to be useful in the study of ELH, particularly in relation to the human MD condition (Aran et al., 1984, Hott et al., 2003, Nadol, 1990). However, this model suffers from some important limitations. First, it requires surgery to produce the phenotype. Second, this model does not reliably produce vestibular symptoms (Horner, 1995). Lastly, and most importantly, induction of ELH by surgical obliteration of the ED is a mechanism that deviates from the spontaneous development of ELH that usually occurs in MD. An animal model that spontaneously develops ELH and hearing loss some time after birth would be a good supplement to the classic guinea pig model.
Mouse mutants have served as useful models for a wide variety of inner ear disorders. A survey of literature for a potential mouse model for hearing loss and ELH drew our attention to a mutant called PhexHyp-Duk (Lorenz-Depiereux et al., 2004). The PhexHyp-Duk mouse harbors a loss-of-function mutation in the Phex gene, and hemizygous males (PhexHyp-Duk/Y) exhibit various phenotypic features including shortened hind legs and tail, hypophosphatemia, hypocalcemia and rickets-like bone disease. In the BALB/cAnBomUrd genetic background, the PhexHyp-Duk/Y mouse develops an ear phenotype that includes variable hearing loss and compromised balance function. A cochlear duct section from a 5-month-old PhexHyp-Duk/Y mouse (only one time point was reported) showed ELH and thickening of the bone surrounding the cochlea with the presence of a precipitate in the scala tympani (Lorenz-Depiereux et al., 2004). This report led us to hypothesize that (a) PhexHyp-Duk/Y mice develop ELH and hearing loss postnatally, and (b) development of ELH in PhexHyp-Duk/Y mice is associated with obstruction of the endolymphatic duct (ED) due to thickening of the surrounding bone. To test these hypotheses, we undertook a detailed characterization of the inner ear phenotype in PhexHyp-Duk/Y mice, and the results are presented here.
Section snippets
Mice
The PhexHyp-Duk allele, a spontaneous mutation in the BALB/cAnBomUrd background (now to be shortened to BALB/cUrd), was obtained from The Jackson Laboratory (TJL). PhexHyp-Duk mutation maintained in the C57BL/6J (B6) background was also available/obtained from TJL. To obtain Phex males and control littermates, BALB/cUrd (or B6) PhexHyp-Duk carrier females (+/PhexHyp-Duk) were bred with BALB/cUrd (or B6) Phex wildtype (+/Y) mice. The Animal Care and Use Committee of CWRU approved the care and
Onset and deterioration of inner ear function
Signs of vestibular dysfunction in PhexHyp-Duk/Y mice were typically observed around P15. This time varied between affected mice from the same litter, although the balance dysfunction became obvious beyond P30 in most cases. Signs of vestibular dysfunction in PhexHyp-Duk/Y mice at 2–3 weeks suggested hearing function might be affected at a young age.
To determine the onset and progression of hearing loss in PhexHyp-Duk/Y mice, click-evoked ABR was measured starting at P21, the age of mature
Discussion
Our search for an animal model that spontaneously develops ELH, hearing loss and degeneration postnatally led us to investigate the PhexHyp-Duk mice in the BALB/cUrd and later in the B6 background. Collectively, data from both studies show that (a) PhexHyp-Duk mice typically develop adult onset, asymmetric, progressive hearing loss closely followed by the onset of ELH (as observed by distention of the Reissner’s membrane), (b) functional degeneration precedes structural degeneration, according
Acknowledgments
We would like to thank Dr. Brian McDermott and Chris Heddon for critical reading of this manuscript. This work was supported by grants to Drs. Alagramam and Megerian from Rainbow Board of Trustees, Rainbow Babies and Children’s Hospitals, University Hospitals Case Medical Center.
References (30)
- et al.
Neuroepithelial defects of the inner ear in a new allele of the mouse mutation Ames waltzer
Hear. Res.
(2000) - et al.
Pathologic significance of Meniere’s symptom complex. A histopathologic and electron microscopic study
Am. J. Otolaryngol.
(1980) Auditory and vestibular function in experimental hydrops
Otolaryngol. Head Neck Surg.
(1995)- et al.
Age-related hearing loss and the ahl locus in mice
Hear. Res.
(2004) Degeneration of cochlear neurons as seen in the spiral ganglion of man
Hear. Res.
(1990)- et al.
Genetics of age-related hearing loss in mice. IV. Cochlear pathology and hearing loss in 25 BXD recombinant inbred mouse strains.
Hear. Res.
(1998) - et al.
Late-onset hearing loss in a mouse model of DFN3 non-syndromic deafness: morphologic and immunohistochemical analyses
Hear. Res.
(2002) - et al.
A new spontaneous mutation in the mouse protocadherin 15 gene
Hear. Res.
(2006) - et al.
Characterization of vestibular dysfunction in the mouse model for Usher syndrome 1F
J. Assoc. Res. Otolaryngol.
(2005) - et al.
Functional and morphological changes in experimental endolymphatic hydrops
Acta Otolaryngol.
(1984)
The role of the endolymphatic sac in the pathogenesis of endolymphatic hydrops in man
Acta Otolaryngol
Familial unilateral deafness and delayed endolymphatic hydrops
Am. J. Med. Genet. A
Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome
Hum. Mol. Genet.
Hearing impairment in familial X-linked hypophosphatemic rickets
Eur. J. Pediatr.
Meniere’s disease and endolymphatic hydrops: clinical-histopathological correlations
Ann. Otol. Rhinol. Laryngol.
Cited by (43)
Localized drug delivery to the middle ear: Recent advances and perspectives for the treatment of middle and inner ear diseases
2022, Journal of Drug Delivery Science and TechnologyApproach to patients with hypophosphataemia
2020, The Lancet Diabetes and EndocrinologyCitation Excerpt :Abnormalities of the inner ear and the otic capsule, endolymphatic hydrops, loss of spiral ganglion cells, and involvement of the cochlea are reported in the genetic forms of hypophosphatemia.53,55 Hearing loss progressively develops even before the structural degeneration, particularly in adulthood, although cases have been reported in children.53,55–57 Tinnitus and Meniere's disease are other possible complications of these genetic forms of the disease.53
Long-term outcomes of endolymphatic sac shunting with local steroids for Meniere's disease
2017, American Journal of Otolaryngology - Head and Neck Medicine and SurgeryTreatment of ear and bone disease in the Phex mouse mutant with dietary supplementation
2017, American Journal of Otolaryngology - Head and Neck Medicine and SurgeryCitation Excerpt :Meniere's disease (MD) is a debilitating condition characterized by episodic vertigo, tinnitus, aural fullness, and progressive sensorineural hearing loss (SNHL) [1]. First described in 1861 by Prosper Meniere, the etiology of MD remains idiopathic although its relationship to endolymphatic hydrops (ELH) has been well established in both human specimens and animal models [2–7]. Therapeutic options for patients with MD range from a conservative low-salt diet to complete ablation of labyrinthine function.
Slc26a4-insufficiency causes fluctuating hearing loss and stria vascularis dysfunction
2014, Neurobiology of DiseaseGenetic and clinical heterogeneity in Meniere's disease
2012, Autoimmunity Reviews